Literature DB >> 9446638

Beta-chemokine receptor CCR5 signals via the novel tyrosine kinase RAFTK.

R K Ganju1, P Dutt, L Wu, W Newman, H Avraham, S Avraham, J E Groopman.   

Abstract

Chemokine receptors are coupled to G-proteins and their activation results in prominent changes in cell migration and growth. The downstream signaling pathways that mediate these effects of chemokines are largely uncharacterized. Macrophage inflammatory protein 1 beta (MIP 1 beta) binding to its cognate receptor CCR5 resulted in activation of the related adhesion focal tyrosine kinase (RAFTK), with subsequent activation of the cytoskeletal protein paxillin and the down-stream transcriptional activators, c-Jun N-terminal kinase (JNK)/stress-activated protein kinase (SAPK) and p38 mitogen-activated protein (MAP) kinase. Inhibition of RAFTK by a dominant-negative kinase mutant markedly attenuated JNK/ SAPK activity. Thus, RAFTK appears to provide a functional "bridge" for the transmission of CCR5 receptor signaling to the cytoskeleton and nucleus, primary sites of chemotaxis and growth regulation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9446638

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  16 in total

1.  Induction of copper/zinc-superoxide dismutase by CCL5/CCR5 activation causes tumour necrosis factor-alpha and reactive oxygen species production in macrophages.

Authors:  Lei Qiu; Li Ding; Jin Huang; Dong Wang; Junping Zhang; Baoyu Guo
Journal:  Immunology       Date:  2008-11-07       Impact factor: 7.397

Review 2.  Chemokines and chemokine receptors: their role in allergic airway disease.

Authors:  M E Rothenberg; N Zimmermann; A Mishra; E Brandt; L A Birkenberger; S P Hogan; P S Foster
Journal:  J Clin Immunol       Date:  1999-09       Impact factor: 8.317

3.  Pharmacological characterization of the chemokine receptor, hCCR1 in a stable transfectant and differentiated HL-60 cells: antagonism of hCCR1 activation by MIP-1beta.

Authors:  Chuan-Chu Chou; Jay S Fine; Catherine Pugliese-Sivo; Waldemar Gonsiorek; Liza Davies; Gregory Deno; Mary Petro; Martin Schwarz; Paul J Zavodny; R William Hipkin
Journal:  Br J Pharmacol       Date:  2002-11       Impact factor: 8.739

4.  Nifedipine suppresses neointimal thickening by its inhibitory effect on vascular smooth muscle cell growth via a MEK-ERK pathway coupling with Pyk2.

Authors:  A Hirata; M Igarashi; H Yamaguchi; A Suwabe; M Daimon; T Kato; M Tominaga
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

5.  Cerebral ischemia and seizures induce tyrosine phosphorylation of PYK2 in neurons and microglial cells.

Authors:  D Tian; V Litvak; S Lev
Journal:  J Neurosci       Date:  2000-09-01       Impact factor: 6.167

6.  Proline-rich tyrosine kinase-2 is critical for CD8 T-cell short-lived effector fate.

Authors:  Sören Beinke; Hyewon Phee; Jonathan M Clingan; Joseph Schlessinger; Mehrdad Matloubian; Arthur Weiss
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-30       Impact factor: 11.205

7.  Abnormal regulation of chemokine TECK and its receptor CCR9 in the endometriotic milieu is involved in pathogenesis of endometriosis by way of enhancing invasiveness of endometrial stromal cells.

Authors:  Yun Wang; Jing Yu; Xuezhen Luo; Xiaoqiu Wang; Mingqing Li; Ling Wang; Dajin Li
Journal:  Cell Mol Immunol       Date:  2010-01       Impact factor: 11.530

8.  Human immunodeficiency virus tat modulates the Flk-1/KDR receptor, mitogen-activated protein kinases, and components of focal adhesion in Kaposi's sarcoma cells.

Authors:  R K Ganju; N Munshi; B C Nair; Z Y Liu; P Gill; J E Groopman
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

9.  First evidence of overlaps between HIV-Associated Dementia (HAD) and non-viral neurodegenerative diseases: proteomic analysis of the frontal cortex from HIV+ patients with and without dementia.

Authors:  Li Zhou; Eve Diefenbach; Ben Crossett; Sieu L Tran; Thomas Ng; Helen Rizos; Rejane Rua; Bin Wang; Amit Kapur; Kaushal Gandhi; Bruce J Brew; Nitin K Saksena
Journal:  Mol Neurodegener       Date:  2010-06-24       Impact factor: 14.195

10.  CCL5-mediated T-cell chemotaxis involves the initiation of mRNA translation through mTOR/4E-BP1.

Authors:  Thomas T Murooka; Ramtin Rahbar; Leonidas C Platanias; Eleanor N Fish
Journal:  Blood       Date:  2008-03-12       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.